TTS Europe

Announcing the Biomedical Innovation Impact Summit 2018.

La Laguna, Tenerife, Spain

The TTS Europe 2018 edition follows on from recent editions in Santiago, Edinburgh, Barcelona, Paris and London, and will take place in La Laguna as part of the 2 day Biomedical Innovation Impact Summit on 26 & 27 November 2018.

The TTS Europe Innovation Day takes place Monday 26 November, and will as always focus on all aspects crucial to early-stage biotech sector innovation, from innovation policy and building a culture of innovation, to technology transfer and licensing, start-up, spin-off, entrepreneurship, strategic business development, industry partnering, venture capital, intellectual property, and bringing together all of the key stakeholder groups for exceptional networking, learning, business development, relationship building, debate and deliberation.

This Tenerife edition has a specific focus on emerging bioregions and early-stage innovation stakeholders and is open to:

  • Faculty, Researchers & Clinicians
  • Technology Transfer, Licensing, & Innovation Professionals
  • Biotech company Executives & Managers
  • Science Parks, incubators, Accelerators, Foundations
  • Post-Docs, Grad students & students with an interest in biotech innovation
  • Investors
  • Intellectual Property, Innovation & Business Professionals
  • Pharma & Industry Research, Scouting, Business Development & Alliance Management Executives

TTS Europe is one of 4 summits that make up the TTS Global Initiative. Numbers are deliberately limited to ensure exclusivity; the summit is *strictly limited to high level leaders and decision-makers from all key stakeholder groups in early stage biotech innovation. The summit takes place under the Chatham House rule to ensure a quality of discussion, interaction, networking and business opportunity unlike any other event in our sector.

Investor Day – 27 November 2018: A special, by invitation Executive Training Programme with leading biotech sector experts in science and innovation, markets and strategy, technology transfer, intellectual property, business models, entrepreneurship, valuations, deal structures, venture capital and biotech sector investing. For further information please contact

Registrationis now open.

*Note: Registration subject to approval. TTS Ltd. reserves the right to approve all registrations to ensure the absolute highest quality of interaction and networking for all participants and members of the TTS Global Initiative.